Literature DB >> 16739087

Frequency of the VO2max plateau phenomenon in world-class cyclists.

A Lucía1, M Rabadán, J Hoyos, M Hernández-Capilla, M Pérez, A F San Juan, C P Earnest, J L Chicharro.   

Abstract

We aimed to determine the frequency of the VO2max plateau phenomenon in top-level male professional road cyclists (n = 38; VO2max [mean +/- SD]: 73.5 +/- 5.5 ml.kg(-1).min(-1)) and in healthy, sedentary male controls (n = 37; VO2max: 42.7 +/- 5.6 ml.kg(-1).min(-1)). All subjects performed a continuous incremental cycle-ergometer test of 1-min workloads until exhaustion. Power output was increased from a starting value of 25 W (cyclists) or 20 W (controls) at the rate of 25 W.min(-1) (cyclists) or 20 W.min(-1) (controls) until volitional exhaustion. We measured gas-exchange and heart rate (HR) throughout the test. Blood concentrations of lactate (BLa) were measured at end-exercise in both groups. We defined maximal exercise exertion as the attainment of a respiratory exchange rate (RER) >or= 1.1; HR > 95 % age-predicted maximum; and BLa > 8 mmo.l(-1). The VO2max plateau phenomenon was defined as an increase in two or more consecutive 1-min mean VO2 values of less than 1.5 ml.kg(-1).min(-1). Most cyclists met our criteria for maximal exercise effort (RER > 1.1, 100 %; 95 % predicted maximal HR [HRmax], 82 %; BLa > 8 mmol.l(-1), 84 %). However, the proportion of cyclists attaining a V.O (2max) plateau was considerably lower, i.e., 47 %. The majority of controls met the criteria for maximal exercise effort (RER > 1.1, 100 %; predicted HRmax, 68 %; BLa > 8 mmol. l(-1), 73 %), but the proportion of these subjects with a VO2max plateau was only 24 % (significantly lower proportion than in cyclists [p < 0.05]). Scientists should consider 1) if typical criteria of attainment of maximal effort are sufficiently stringent, especially in elite endurance athletes; and 2) whether those humans exhibiting the VO2max plateau phenomenon are those who perform an absolute maximum effort or there are additional distinctive features associated with this phenomenon.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16739087     DOI: 10.1055/s-2006-923833

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  23 in total

1.  A new incremental test for VO₂max accurate measurement by increasing VO₂max plateau duration, allowing the investigation of its limiting factors.

Authors:  Hélène Petot; Renaud Meilland; Laurence Le Moyec; Laurence Mille-Hamard; Véronique L Billat
Journal:  Eur J Appl Physiol       Date:  2011-10-14       Impact factor: 3.078

2.  Level ground and uphill cycling ability in elite female mountain bikers and road cyclists.

Authors:  F M Impellizzeri; T Ebert; A Sassi; P Menaspà; E Rampinini; D T Martin
Journal:  Eur J Appl Physiol       Date:  2007-10-18       Impact factor: 3.078

3.  Prior Knowledge of Trial Number Influences the Incidence of Plateau at VO2max.

Authors:  Dan Gordon; Oliver Caddy; Viviane Merzbach; Marie Gernigon; James Baker; Adrian Scruton; Don Keiller; Richard Barnes
Journal:  J Sports Sci Med       Date:  2015-03-01       Impact factor: 2.988

4.  Ramp-incremented and RPE-clamped test protocols elicit similar VO2max values in trained cyclists.

Authors:  Allison M Straub; Adrian W Midgley; Gerald S Zavorsky; Angela R Hillman
Journal:  Eur J Appl Physiol       Date:  2014-04-29       Impact factor: 3.078

5.  Is a verification phase needed to determine [Formula: see text]O2max across fitness levels?

Authors:  Seth F McCarthy; Jarryd M P Leung; Tom J Hazell
Journal:  Eur J Appl Physiol       Date:  2021-01-02       Impact factor: 3.078

6.  Cardiopulmonary Exercise Testing in Athletes: Expect the Unexpected.

Authors:  Bradley J Petek; Sarah K Gustus; Meagan M Wasfy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-05-12

Review 7.  Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit.

Authors:  Jules A A C Heuberger; Joost M Cohen Tervaert; Femke M L Schepers; Adriaan D B Vliegenthart; Joris I Rotmans; Johannes M A Daniels; Jacobus Burggraaf; Adam F Cohen
Journal:  Br J Clin Pharmacol       Date:  2013-06       Impact factor: 4.335

8.  VO2max during successive maximal efforts.

Authors:  Carl Foster; Erin Kuffel; Nicole Bradley; Rebecca A Battista; Glenn Wright; John P Porcari; Alejandro Lucia; Jos J deKoning
Journal:  Eur J Appl Physiol       Date:  2007-09-22       Impact factor: 3.346

9.  Effects of 7-day intake of hydrogen-rich water on physical performance of trained and untrained subjects.

Authors:  Rafael Timón; Guillermo Olcina; Adrian González-Custodio; Marta Camacho-Cardenosa; Alba Camacho-Cardenosa; Ismael Martínez Guardado
Journal:  Biol Sport       Date:  2020-10-22       Impact factor: 2.806

10.  Effects of eight-week supplementation of Ashwagandha on cardiorespiratory endurance in elite Indian cyclists.

Authors:  Shweta Shenoy; Udesh Chaskar; Jaspal S Sandhu; Madan Mohan Paadhi
Journal:  J Ayurveda Integr Med       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.